Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05413382 · ClinicalTrials.gov registry record · NA
Effect of an Investigational Lozenge (Biofresh® 4plus) Versus Placebo Control on Oral Malodor (Intra-Oral Halitosis)
A NA study, sponsored by Novozymes A/S.
- Completed
- Registry status
- NA
- Development phase
- 53
- Enrollment target
NCT05413382 is a NA study that has completed, run by Novozymes A/S. The registered enrollment target is 53 participants.
The verdict
NCT05413382, a NA study, has completed, sponsored by Novozymes A/S.
- COMPLETED
- Registry status
- NA
- Development phase
- 53 participants
- Enrollment target
Study Summary
This study is designed to evaluate the effect of an investigational lozenge with the enzyme polyphenol oxidase and green coffee extract in reducing and controlling intra-oral halitosis following immediate use and daily use of the lozenge over a one-week period.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Biofresh® 4plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2021-09-28 |
| Est. Completion | 2021-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05413382
The ClinicalTrials.gov registry entry for NCT05413382 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 53 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novozymes A/S, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05413382 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05413382 about?
NCT05413382 is a clinical study titled "Effect of an Investigational Lozenge (Biofresh® 4plus) Versus Placebo Control on Oral Malodor (Intra-Oral Halitosis)". This study is designed to evaluate the effect of an investigational lozenge with the enzyme polyphenol oxidase and green coffee extract in reducing and controlling intra-oral halitosis following immediate use and daily use of the lozenge over a one-week period.
What is the current status of trial NCT05413382?
This trial is currently completed. It is a NA study. The enrollment target is 53 participants. The study started on 2021-09-28. Estimated completion is 2021-12-22.
What interventions are being tested in trial NCT05413382?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Biofresh® 4plus (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05413382?
This trial is sponsored by Novozymes A/S, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.